WellCare price target raised to $69 from $62 at Susquehanna Susquehanna raised its price target on WellCare to reflect improved visibility on near-term earnings which should lead to a further positive revaluation of the shares. Shares are Positive rated.
News For WCG From The Last 14 Days
Check below for free stories on WCG the last two weeks.
WellCare downgraded at Wedbush As noted earlier, Wedbush downgraded WellCare to Neutral from Outperform. The firm no longer sees the company as a takeover candidate, and it thinks that the company will need at least 2-3 years to turn itself around. Target to $55 from $70.